Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
CARDURA
Generic name / active ingredient
doxazosin immediate-release tablets
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-09-02

Copy from the pack in hand

Source-linked reading points

  • The label warns about postural hypotension, dizziness and syncope, particularly when starting, increasing a strength or resuming after interruption. Older adults, people with falls or another blood-pressure medicine require priority full-list review; the site generates no restart or titration plan.
  • PDE-5 inhibitors such as CIALIS or VIAGRA can add to blood-pressure lowering and cause symptomatic hypotension with CARDURA; strong CYP3A inhibitors may also increase exposure. Do not self-separate, halve or stop a pack.
  • Before cataract surgery, tell the eye team about current or previous CARDURA/other alpha-1 blocker use. The label does not support self-stopping for this reason.
  • The 2, 4 and 8 mg tablets are scored, but the score is an appearance clue for the exact product—not website permission to split, change an amount or replace another strength.

Reviewed presentation examples — compare every field

  • Doxazosin 1 mg per tablet; 100-tablet bottleNDC 58151-074-01
  • Doxazosin 2 mg per tablet; 100-tablet bottleNDC 58151-075-01
  • Doxazosin 4 mg per tablet; 100-tablet bottleNDC 58151-076-01
  • Doxazosin 8 mg per tablet; 100-tablet bottleNDC 58151-077-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-02
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image